MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-1829

  1. 12,543 Posts.
    lightbulb Created with Sketch. 3394
    This is great, get the message out there - loud and clear!

    But, "Mount Sinai Health System will be conducting a study using remestemcel-L (Ryoncil)"; does this mean that the trial has not commenced?
    Last edited by ddwn: 23/04/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.